Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CLMT | Common Stock, par value $0.01 per share | Award | $218K | +10K | +6.2% | $21.78 | 171K | Nov 22, 2024 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CLMT | Call Option (right to buy) | Sale | -$252K | -900 | -100% | $280.00* | 0 | Nov 21, 2024 | Common Stock, par value $0.01 per share | 90K | $20.00 | Direct | F1 |
Id | Content |
---|---|
F1 | On November 21, 2024, the reporting person sold 900 call options, which were options to buy 90,000 shares of Calumet, Inc. common stock, at an exercise price of $20 per share and with an expiration date of January 17, 2025. The reporting person received total proceeds of $252,003 from the sale of the call options, of which $217,800 was used to fund the purchase of 10,000 shares of Calumet, Inc. common stock reported herein, and the remaining proceeds are intended to satisfy certain tax obligations that were incurred in connection with the sale of the call options. |